Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/03/2012CN102146412B Small molecular non-coding RNA gene hsa-miR-29b and use thereof
10/03/2012CN102139107B Anticancer effect of antagonist of neurokinin receptor
10/03/2012CN102133236B Toad peptide antibiotics for preparing medicine for curing lung cancer
10/03/2012CN102079771B Estrogen amino-acid ester compound with antitumor activity as well as synthetic method thereof
10/03/2012CN102058631B Seabuckthorn leaf extract preparation and preparation method thereof
10/03/2012CN102048737B Pharmaceutical composition for treating tumor diseases
10/03/2012CN102048681B Mifepristone slow release preparation characterized by gastric stasis and preparation method thereof
10/03/2012CN101982171B Application of fenugreek biflavone glycosides for preparing anti-virus or/and anti-tumor drugs
10/03/2012CN101967164B Ruthenium (II) complex, preparation method thereof and application thereof to preparation of antitumor medicaments
10/03/2012CN101948473B New NEO-clerodane diterpenoid compound and application thereof
10/03/2012CN101945870B 5-anilinoimidazopyridines and methods of use
10/03/2012CN101928259B 2-arylthiazole derivative and medicament composition thereof
10/03/2012CN101914080B Benzofuran-3-ketone substitute phenyl compound as well as preparation method and application
10/03/2012CN101890162B New use of PEG-PCL-PEG (polyethylene glycol-polycaprolactone-polyethylene glycol) and antigen-assembled mixture
10/03/2012CN101889998B Composition and application thereof as TR3 receptor inducer
10/03/2012CN101863844B Synthesis method of 6,7-substituted-4-aniline quinazoline
10/03/2012CN101845009B Structural carotenoid analogs for the inhibition and amelioration of disease
10/03/2012CN101836958B Preparation of taxane pH sensitive nanoparticles composite for oral administration and application thereof
10/03/2012CN101829187B Preparation method of fruit-flavored cyclocarya paliurus chewable tablets
10/03/2012CN101829169B Medicament for treating tumors
10/03/2012CN101827824B Crystalline chemotherapeutic
10/03/2012CN101827823B Crystalline chemotherapeutic
10/03/2012CN101792763B Antisense oligonucleotide for specifically adjusting POKEMON gene expression and application thereof
10/03/2012CN101704792B Quinoxalinone derivative with matrix metalloproteinase inhibitory activity and preparation method and application thereof
10/03/2012CN101679321B Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
10/03/2012CN101671390B Human interferon alpha derivatives and preparation and use of pegylated products thereof
10/03/2012CN101648937B Isoflavones compound and preparation and application thereof
10/03/2012CN101643490B Epothilonoside compound, preparation method and application as cytostatics thereof
10/03/2012CN101643484B High-purity syringin, preparation method and application
10/03/2012CN101580477B Dehydroabietylamine derivatives and application thereof in bactericidal and antineoplastic medicaments
10/03/2012CN101563366B Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases
10/03/2012CN101516375B Combinations of class-I specific histone deacetylase inhibitors with proteasome inhibitors
10/03/2012CN101511368B Compositions for promoting activity of anti-cancer therapies.
10/03/2012CN101490000B 2-arylindole derivatives as NPGES-1inhibitors
10/03/2012CN101472597B Inhibitor of expression of nuclear transcription factor AP-1, and pharmaceutical product and product using the inhibitor
10/03/2012CN101417067B Medicine combination with anti-tumor function
10/03/2012CN101389624B 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
10/03/2012CN101358200B RNA interference expression plasmid- cationic liposome-heparin antineoplastic complexes targeting human FAK and PLK1 gene
10/03/2012CN101222850B Methods for treating drug resistant cancer
10/03/2012CN101186612B Pyrroline derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application
10/03/2012CN101011574B Use of an anti-il6 receptor antibody for preparing pharmaceutical composition
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012US8278351 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications
10/02/2012US8278348 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
10/02/2012US8278314 Quinazoline analogs as receptor tyrosine kinase inhibitors
10/02/2012US8278292 Therapeutic compositions
10/02/2012US8278291 Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof
10/02/2012US8278265 Methods, kits and compositions comprising crotamine
10/02/2012US8278103 Oligonucleotides comprising alternating segments and uses thereof
10/02/2012US8278098 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/02/2012US8278042 Compositions and methods for the diagnosis and treatment of tumor
10/02/2012US8277847 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
10/02/2012US8277839 Oral pharmaceutical composition of anilinopyrimidine, preparation and use thereof
10/02/2012US8277818 Herpes virus strains for gene therapy
10/02/2012US8277806 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
10/02/2012US8277802 Diagnosis and prevention of cancer cell invasion
10/02/2012CA2690953C Benzimidazole derivatives
10/02/2012CA2641138C Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
10/02/2012CA2576926C Use of midostaurin for treating gastrointestinal stromal tumors
10/02/2012CA2575720C Pyrimidine derivatives
10/02/2012CA2530038C Vaccines comprising polynucleotides
10/02/2012CA2529453C Pyrrolidin-1,2-dicarboxylic acid-1-[(4-ethinyl-phenyl)-amide]-2-[(phenyl)-amide] derivative as inhibitors of coagulation factors xa and viia for the treatment of thromboses
10/02/2012CA2520172C Novel methods for the treatment of cancer with an indoleamine 2, 3-dioxygenase inhibitor
10/02/2012CA2520115C 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
10/02/2012CA2502848C Use of irl-1620 and paclitaxel for preventing and treating breast tumors
10/02/2012CA2502531C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/02/2012CA2487779C P53 binding t cell receptor molecules and uses thereof
10/02/2012CA2484192C Formulation of a mixture of free-b-ring flavonoids and flavans as a therapeutic agent
10/02/2012CA2478111C A cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and antimicrobial treatment following high-dose cytotoxic chemotherapy
10/02/2012CA2466477C A2b adenosine receptor antagonists
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2438270C Process for the fractionation of cereal brans
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2427477C Active variants of fgf with improved specificity
10/02/2012CA2417874C Use of ox-2 inhibitors for the treatment of cancer
10/02/2012CA2412795C Improved liposomal camptothecins and uses thereof
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
09/2012
09/27/2012WO2012129564A2 Proteasome chymotrypsin-like inhibition using pi-1833 analogs
09/27/2012WO2012129514A1 Method and compositions for cellular immunotherapy
09/27/2012WO2012129473A1 Gallium complexes, pharmaceutical compositions and methods of use
09/27/2012WO2012129394A2 Methods and compositions for the treatment of cancer
09/27/2012WO2012129353A1 Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
09/27/2012WO2012129344A1 Fused tricyclic dual inhibitors of cdk 4/6 and flt3
09/27/2012WO2012129338A1 Azole compounds as pim inhibitors
09/27/2012WO2012129335A2 Hyd1 peptides for relapsed cancer
09/27/2012WO2012129145A1 Nscle combination therapy
09/27/2012WO2012128998A2 Method for delivering gene and cell therapy to a tumor or targeted site using an implanted metronomic biofeedback pump
09/27/2012WO2012128868A1 Cytotoxic benzodiazepine derivatives
09/27/2012WO2012128709A1 A pharmaceutical composition comprising a hdac inhibitor and a steroid and the use thereof.
09/27/2012WO2012128689A1 Treatment of solid tumours
09/27/2012WO2012128653A1 Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer
09/27/2012WO2012128530A2 2-methyl-2-alkyl-6-amido-2h-benzopyran derivatives having anti-cancer activity
09/27/2012WO2012128521A2 Pharmaceutical composition for treating aging-associated diseases, containing progerin expression inhibitor as active ingredient, and screening method of said progerin expression inhibitor
09/27/2012WO2012128377A1 Composition for treatment and diagnosis of pancreatic cancer
09/27/2012WO2012128326A1 Nanoparticles for photo dynamic therapy
09/27/2012WO2012128082A1 Anti-mouse aggrus monoclonal antibody
09/27/2012WO2012127885A1 Tetrahydrocarboline derivative
09/27/2012WO2012127739A1 Novel carrier molecule and method both for delivering rna into cytoplasm using near-infrared light
09/27/2012WO2012127506A1 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
09/27/2012WO2012127493A1 Polymorphs of lenalidomide
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 2211